Investor: David Goel
Number of Assets: 4
Reporting Period: Q2 - 2025
Holdings at Report: $222,781,213
Return Since Report: -$10,936,449
Return Since Report: -4.91%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Globalfoundries Inc. (GFS) | Equity | -50.11% | 3,475,000 | 59.59% | $38.20 | $32.13 | $132,745,000 | $111,651,750 | -$21,093,250 | -15.89% |
| Zentalis Pharmaceuticals Inc. (ZNTL) | Equity | 0% | 13,959,973 | 7.27% | $1.16 | $1.62 | $16,193,569 | $22,545,356 | +$6,351,787 | +39.22% |
| Aura Biosciences Inc. (AURA) | Equity | 0% | 6,922,870 | 19.45% | $6.26 | $5.26 | $43,337,166 | $36,414,296 | -$6,922,870 | -15.97% |
| Maze Therapeutics Inc. (MAZE) | Equity | 0% | 2,486,184 | 13.69% | $12.27 | $16.59 | $30,505,478 | $41,233,362 | +$10,727,884 | +35.17% |